Conash Or Inc — research payments reported

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$73,099	5
2024	Research	$1,150	1
2023	Research	$10,724	2
2022	Research	$25,377	3
2021	Research	$132,362	2
2020	Research	$140,452	7

Breakdown

Who paid Research payments · program years 2020–2025

Eli Lilly and Company $186,446 9 payments
VYNE Pharmaceuticals Inc. $129,593 6 payments
Galderma Laboratories, L.P. $65,975 4 payments
Avita Medical Americas, LLC $1,150 1 payment

Studies the money was for Research payments · program years 2020–2025

A Phase 3, 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-To-Severe Atopic Dermatitis $129,748 3 payments
Fx2016-40 $129,593 6 payments
A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey Skin $64,975 3 payments
A Long-Term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-To-Severe Atopic Dermatitis $45,975 4 payments
A Phase 3 16-Week Randomized Double-Blind Placebo-Controlled Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-To-Severe Atopic Dermatitis $6,473 1 payment
A Long-Term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-To-Severe Atopic Dermatitis $4,252 1 payment
A Prospective Post-Market Clinical Study Investigating Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin Cells $1,150 1 payment
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Assess Aesthetic Improvement and Onset of QM1114-DP Treatment Effect in Subjects With Moderate to Severe Glabellar Lines $1,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.